| Current Price | $336.77 | Mkt Cap | $295.6B |
|---|---|---|---|
| Open | $333.53 | P/E Ratio | 45.97 |
| Prev. Close | $311.10 | Div. (Yield) | $3.92 (1.3%) |
| Daily Range | $328.10 - $341.70 | Volume | 6,066,875 |
| 52-Wk Range | $220.20 - $341.70 | Avg. Daily Vol. | 2,767,815 |
The Company discovers, develops, manufactures and sells products in one of its business segment of pharmaceutical products to prevent and treat human diseases.
| Current Price | $336.77 | Mkt Cap | $295.6B |
|---|---|---|---|
| Open | $333.53 | P/E Ratio | 45.97 |
| Prev. Close | $311.10 | Div. (Yield) | $3.92 (1.3%) |
| Daily Range | $328.10 - $341.70 | Volume | 6,066,875 |
| 52-Wk Range | $220.20 - $341.70 | Avg. Daily Vol. | 2,767,815 |
The best Bull and Bear pitches based on recency and number of recommendations.
For reference point and to allow for comments by others. As of the end of March, 2013.ROE 31.07%Trailing PE 12.78PB 3.92Div yield 3.60%
Read the most recent pitches from players about LLY.
Recs
advcards
(25.00)
Submitted: 9/13/2022 11:51:35 AM :
Start Price:
$308.79
NYSE:LLY Score:
+17.00
Weight Loss Drug
Recs
mrbill6
(59.26)
Submitted: 6/16/2022 2:42:46 PM :
Start Price:
$284.36
NYSE:LLY Score:
+18.08
A stock that will beat the doomsday crash
Recs
TMFkodyk123
(71.07)
Submitted: 8/21/2021 4:30:49 PM :
Start Price:
$269.39
NYSE:LLY Score:
+42.82
Eli Lilly's top-notch diabetes drug portfolio led by Trulicity, as well as its plaque psoriasis and psoriatic arthritis blockbuster Taltz should lead to mid-teen annual earnings growth in the foreseeable future. While Eli Lilly isn't a bargain buy at 34 times this year's earnings forecast, its growth prospects make up for its price.
Find the members with the highest scoring picks in LLY.
thomasgb (38.21) Score: +1,333.22
The Score Leader is the player with the highest score across all their picks in LLY.
|
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
|---|---|---|---|---|---|---|---|---|---|---|
| thomasgb | 38.21 | 3/4/2009 |
|
3Y | $18.20 | +1,758.76% | +425.54% | +1,333.22 | 0 Comment | |
| MarketPwnage | 78.48 | 3/9/2009 |
|
NS | $18.04 | +1,774.90% | +451.38% | +1,323.52 | 0 Comment | |
| tektan | 88.92 | 3/9/2009 |
|
5Y | $18.04 | +1,774.90% | +451.38% | +1,323.52 | 0 Comment | |
| MCMInvest | 72.72 | 3/9/2009 |
|
NS | $18.04 | +1,774.90% | +451.38% | +1,323.52 | 0 Comment | |
| harryhotspur1403 | 68.83 |
|
|
1Y | $19.42 | +1,641.82% | +335.20% | +1,306.61 | 0 Comment | |
| LordCoolio | 67.73 | 3/2/2009 |
|
3M | $18.57 | +1,721.01% | +416.84% | +1,304.17 | 0 Comment | |
| fredericch | 97.64 | 3/2/2009 |
|
NS | $18.57 | +1,721.01% | +416.84% | +1,304.17 | 0 Comment | |
| eyeseeu2 | 97.94 | 11/21/2008 |
|
NS | $18.95 | +1,684.50% | +387.84% | +1,296.66 | 0 Comment | |
| srdreyer | 74.95 | 10/28/2008 |
|
1Y | $19.54 | +1,630.53% | +338.67% | +1,291.86 | 0 Comment | |
| juliehowe | 66.68 | 10/28/2008 |
|
1Y | $19.67 | +1,619.36% | +330.28% | +1,289.08 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.
